her 2 the making of herceptin a revolutionary trea
Tre Macejkovic DVM
—
oclonal antibody, known scientifically as trastuzumab, transformed the prognosis for millions of women diagnosed with HER2-positive breast cancer. Its development exemplifies the power of targeted therapy, pers
